Cargando…
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
Autores principales: | Hausenloy, Derek J., Botker, Hans Erik, Engstrom, Thomas, Erlinge, David, Heusch, Gerd, Ibanez, Borja, Kloner, Robert A., Ovize, Michel, Yellon, Derek M., Garcia-Dorado, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381598/ https://www.ncbi.nlm.nih.gov/pubmed/27118196 http://dx.doi.org/10.1093/eurheartj/ehw145 |
Ejemplares similares
-
Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction
por: Bøtker, Hans Erik, et al.
Publicado: (2020) -
Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
por: Kleinbongard, Petra, et al.
Publicado: (2020) -
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
por: Hausenloy, Derek J., et al.
Publicado: (2016) -
ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery
por: Thielmann, Matthias, et al.
Publicado: (2017) -
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)